From Germline Susceptibility to Somatic Evolution: The Genetic Trajectory of Pancreatic Ductal Adenocarcinoma and Implications for Screening and Early Detection
Cancer Screening and Prevention · 30.12.2026
DOI: 10.14218/csp.2026.00014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Screening and Prevention, online erschienen am 16.11.2026. Verfasst von Chenshan Ma und 9 weiteren Autor:innen. Die Arbeit nennt 90 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ma, C., Zhu, H., Li, Z., Qiu, Y., Liu, X., Zhai, X., Jiang, K., Lu, Z., Gao, W., & Yin, L. (2026). From Germline Susceptibility to Somatic Evolution: The Genetic Trajectory of Pancreatic Ductal Adenocarcinoma and Implications for Screening and Early Detection. Cancer Screening and Prevention. https://doi.org/10.14218/csp.2026.00014
Vancouver
Ma C, Zhu H, Li Z, Qiu Y, Liu X, Zhai X, et al. From Germline Susceptibility to Somatic Evolution: The Genetic Trajectory of Pancreatic Ductal Adenocarcinoma and Implications for Screening and Early Detection. Cancer Screening and Prevention. 2026. doi:10.14218/csp.2026.00014
BibTeX
@article{Ma2026,
author = {Ma, Chenshan and Zhu, Hanyu and Li, Zhenyu and Qiu, Yichen and Liu, Xue and Zhai, Xinyue and Jiang, Kuirong and Lu, Zipeng and Gao, Wentao and Yin, Lingdi},
title = {From Germline Susceptibility to Somatic Evolution: The Genetic Trajectory of Pancreatic Ductal Adenocarcinoma and Implications for Screening and Early Detection},
journal = {Cancer Screening and Prevention},
year = {2026},
doi = {10.14218/csp.2026.00014}
}
EUVIMED